Lineage Cell Therapeutics, Inc.
Cash Flow Statement
| Line Item | FY2009 |
|---|---|
| Operating Activities | |
| Net Income | $-5.1M |
| Depreciation & Amortization | — |
| Depreciation | $34.6K |
| Amortization | $0 |
| Stock-Based Compensation | $260.8K |
| Net Cash from Operating Activities | $-4.3M |
| Investing Activities | |
| Capital Expenditures | $61.3K |
| Business Acquisitions | $0 |
| Net Cash from Investing Activities | $-46.2K |
| Financing Activities | |
| Dividends Paid | — |
| Stock Repurchases | — |
| Net Cash from Financing Activities | $16.5M |
| Net Change in Cash | $12.2M |
| Free Cash Flow | $-4.3M |